← Open Payments lookup

MALCOLM DUNCAN: Open Payments

NPI 1033691746 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,062 in 127 payments from 10 companies in 2025. Trend: 2023 $5,535 · 2024 $17,329 · 2025 $8,062

Speaker / faculty: $4,308Food & beverage: $3,269Travel & lodging: $250Consulting: $155Education: $80
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.62$6,135
Alkermes, Inc.24$759
Neurocrine BioSciences, Inc.17$401
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$263
E.R. Squibb & Sons, L.L.C.8$247
Janssen Pharmaceuticals, Inc5$134
Otsuka America Pharmaceutical, Inc.2$45
Alpha Cognition USA, Inc.1$36
ABBVIE INC.1$23
Lundbeck LLC1$19

Products named: AUSTEDO XR, UZEDY, ARISTADA, INGREZZA, CAPLYTA, COBENFY, INVEGA SUSTENNA, LYBALVI.

Industry payments across TX — which companies pay providers there.